Log in
Enquire now
Resverlogix

Resverlogix

A company developing epigenetic therapeuticsto treat heart disease, diabetes, chronic kidney disease and other illnesses

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
AngelList URL
angel.co/resverlogix
B2X
B2B
B2B
0
Legal Name
Resverlogix Corp.
Company Operating Status
Active
Country
United States
United States
0
Canada
Canada
0
Email Address
info@resverlogix.com
0
Founded Date
2001
0
Founder
‌
Norman C.W. Wong
0
Full Address
535 Mission St, 14th Floor San Francisco, CA, USA, 94105
0
300, 4820 Richard Road SW Calgary, AB, CANADA, T3E 6L1
0
Headquarters
Calgary
Calgary
0
Industry
Consumer biotechnology
Consumer biotechnology
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Healthcare
Healthcare
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Engineering
Engineering
Investors
Yorkville Advisors
Yorkville Advisors
Latest Funding Round Date
August 14, 2013
Latest Funding Type
Seed
Seed
LinkedIn URL
@company/resverlogix-corp-
Location
Calgary
Calgary
0
Canada
Canada
San Francisco
San Francisco
0
Number of Employees (Ranges)
11 – 50
0
Patents Assigned (Count)
4
Pitchbook URL
pitchbook.com/profiles.../53791-66
Exchange
Toronto Stock Exchange
Toronto Stock Exchange
Stock Symbol
RVX
Total Funding Amount (USD)
28,441,995
Twitter URL
@Resverlogix_RVX
Official Website
resverlogix.com
Wellfound ID
resverlogix

Find more companies like Resverlogix

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.